M&A - ZimVie Inc.

Form Type: 10-Q

Filing Date: 2025-05-08

Corporate Action: Acquisition

Type: Update

Accession Number: 000095017025066986

Filing Summary: ZimVie Inc. provided a detailed overview of its financial performance for the quarterly period ending March 31, 2025, highlighting a net loss of $1.471 million as compared to a net loss of $7.761 million for the same period in 2024. The company's net sales decreased from $118.195 million to $111.997 million year-over-year. Cost of products sold and other operating expenses were analyzed, showing a reduction in various operational costs. The report also discusses the impacts of the acquisition of the spine segment, completed in April 2024 for $375 million, which has been classified as discontinued operations in accordance with accounting standards. Forward-looking statements were provided, addressing potential risks related to market conditions, competition, and regulatory challenges. The filing shows an increase in comprehensive income due to foreign currency adjustments. ZimVie continues its focus on enhancing dental technology and recovering from previous operational challenges following the spin-off from Zimmer Biomet.